Page last updated: 2024-08-16

ribavirin and Vitiligo

ribavirin has been researched along with Vitiligo in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arama, V; Popescu, C; Popescu, GA1
Kawada, A; Oiso, N; Sato, M1
Abdo, AA; Alajlan, A; Binamer, Y; Hamadah, I; Sanai, FM1
Cacayorin, E; Cedron, H; Kato, T; Levi, D; Moon, J; Nishida, S; Pyrsopoulos, N; Schiff, E; Selvaggi, G; Taffaro, M; Tzakis, A; Weppler, D1

Other Studies

4 other study(ies) available for ribavirin and Vitiligo

ArticleYear
Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
    Journal of gastrointestinal and liver diseases : JGLD, 2013, Volume: 22, Issue:1

    Topics: Antiviral Agents; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hashimoto Disease; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon-alpha; Islets of Langerhans; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitiligo; Young Adult

2013
Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
    The Journal of dermatology, 2013, Volume: 40, Issue:9

    Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitamin D; Vitamin D Deficiency; Vitiligo

2013
Interferon-induced vitiligo in hepatitis C patients: a case series.
    International journal of dermatology, 2010, Volume: 49, Issue:7

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Vitiligo

2010
Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:12

    Topics: Antiviral Agents; Drug Carriers; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load; Vitiligo

2007